Reply
Brian J. McMahon – 6 December 2021
Superior Long‐Term Outcomes of Adult Living Donor Liver Transplantation: A Cumulative Single‐Center Cohort Study With 20 Years of Follow‐Up
Toru Goto, Tommy Ivanics, Mark S. Cattral, Trevor Reichman, Anand Ghanekar, Gonzalo Sapisochin, Ian D. McGilvray, Blayne Sayed, Les Lilly, Mamatha Bhat, Markus Selzner, Nazia Selzner – 5 December 2021 – Living donor liver transplantation (LDLT) is an attractive alternative to deceased donor liver transplantation (DDLT). Although both modalities have similar short‐term outcomes, long‐term outcomes are not well studied. We compared the 20‐year outcomes of 668 adults who received LDLT with1596 DDLTs at the largest liver transplantation (LT) program in Canada.
Introducing Laurie DeLeve, M.D., Ph.D., Our 2022 AASLD President
Neil Kaplowitz – 5 December 2021
Introducing Laurie DeLeve, M.D., Ph.D., Our 2022 AASLD President
Neil Kaplowitz – 5 December 2021
Suppressed farnesoid X receptor by iron overload in mice and humans potentiates iron‐induced hepatotoxicity
Hui Xiong, Chunze Zhang, Lifeng Han, Tong Xu, Khawar Saeed, Jing Han, Jing Liu, Curtis D. Klaassen, Frank J. Gonzalez, Yuanfu Lu, Youcai Zhang – 5 December 2021
Letter to the editor: Exacerbation of autoimmune hepatitis after COVID‐19 vaccination
Zhujun Cao, Honglian Gui, Zike Sheng, Haiguang Xin, Qing Xie – 3 December 2021
Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study
Jennifer C. Lai, Amy M. Shui, Andres Duarte‐Rojo, Daniel R. Ganger, Robert S. Rahimi, Chiung‐Yu Huang, Frederick Yao, Matthew Kappus, Brian Boyarsky, Mara McAdams‐Demarco, Michael L. Volk, Michael A. Dunn, Daniela P. Ladner, Dorry L. Segev, Elizabeth C. Verna, Sandy Feng, from the Multi‐Center Functional Assessment in Liver Transplantation (FrAILT) Study – 3 December 2021
Big Data for Small People: How Novel Data Collection Can Improve Pediatric Transplantation Outcomes
M. Andrew Millis, Shannon L. Cramm, Michael Englesbe – 2 December 2021
Reply
Andrew I. Aronsohn, Debika Bhattacharya, Timothy R. Morgan, David L. Wyles, Raymond T. Chung, Daniel P. McQuillen, AASLD‐IDSA HCV Guidance – 2 December 2021
Secondary Prophylaxis of Gastric Variceal Bleeding: A Systematic Review and Network Meta‐Analysis
Karim T. Osman, Tarek Nayfeh, Ahmed M. Abdelfattah, Khaled Alabdallah, Bashar Hasan, Mohammed Firwana, Homam Alabaji, Lina Elkhabiry, Jehan Mousa, Larry J. Prokop, M. Hassan Murad, Fredric Gordon – 2 December 2021 – There is no clear consensus regarding the optimal approach for secondary prophylaxis of gastric variceal bleeding (GVB) in patients with cirrhosis. We conducted a systematic review and network meta‐analysis (NMA) to compare the efficacy of available treatments.